Press Page Brenda Schulman

The department of Molecular Machines and Signaling was established in July 2017. We focus on understanding how ubiquitin (UB) and UB-like protein modifications direct extraordinary changes in the fates of their targets, such as altering stability, subcellular localization, interactions, or conformation.

The vision for the department is to combine biochemical reconstitution, structure, enzymology, chemistry, protein design, cell biology and genetics – along with other cutting-edge technologies in collaboration with close colleagues (Especially in neighboring departments) – in an integrated and circular process, with continuous flow of information between methodologies.


Max Planck Director Brenda Schulman receives prestigious science award

The 2023 Louis-Jeantet Prize for Medicine is awarded jointly to Brenda Schulman and Ivan Ðikić, for their outstanding contributions to the ubiquitin research field. more

ASAP Grant for 3 MPIB Directors

Brenda Schulman, Ulrich Hartl and Wolfgang Baumeister receive a research grant to study Mechanisms of Parkinsons’s disease more

<strong>In the right place at the right time</strong>

Scientists at the Max Planck Institute of Biochemistry (MPIB) decipher the activation chain of protein degradation more

Show more
Go to Editor View